Deficiency in asparagine synthetase expression in rectal cancers receiving concurrent chemoradiotherapy: negative prognostic impact and therapeutic relevance

Asparagine synthetase: regulation by cell stress and involvement in tumor biology

(2013) Mukundh N. Balasubramanian et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Asparagine synthetase is an independent predictor of surgical survival and a potential therapeutic target in hepatocellular carcinoma

(2013) B Zhang et al.   BRITISH JOURNAL OF CANCER

ASS1 as a Novel Tumor Suppressor Gene in Myxofibrosarcomas: Aberrant Loss via Epigenetic DNA Methylation Confers Aggressive Phenotypes, Negative Prognostic Impact, and Therapeutic Relevance

(2013) H.-Y. Huang et al.   CLINICAL CANCER RESEARCH

Overexpression of Asparagine Synthetase and Matrix Metalloproteinase 19 Confers Cisplatin Sensitivity in Nasopharyngeal Carcinoma Cells

(2013) R.-Y. Liu et al.   MOLECULAR CANCER THERAPEUTICS

SKP2 overexpression is associated with a poor prognosis of rectal cancer treated with chemoradiotherapy and represents a therapeutic target with high potential

(2013) Yu-Feng Tian et al.   TUMOR BIOLOGY

Deficiency in expression and epigenetic DNA Methylation of ASS1 gene in nasopharyngeal carcinoma: negative prognostic impact and therapeutic relevance

(2013) Jui Lan et al.   TUMOR BIOLOGY

Pancreatic Tumor Sensitivity to Plasma L-Asparagine Starvation

(2012) Emmanuelle Dufour et al.   PANCREAS

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

Asparagine synthetase is a predictive biomarker of l-asparaginase activity in ovarian cancer cell lines

(2008) Philip L. Lorenzi et al.   MOLECULAR CANCER THERAPEUTICS